Richard Kobza

Showing 1-3 of 3 articles

Interventions for valvular disease

First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation

Toggweiler S, De Boeck B, Brinkert M, Buhmann R, Bossard M, Kobza R, Cuculi F

September 20, 2018 | 10.4244/EIJ-D-18-00440

Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation

Toggweiler S, Nissen H, Mogensen B, Cuculi F, Fallesen C, Veien K, Brinkert M, Kobza R, Rück A

December 20, 2017 | 10.4244/EIJ-D-17-00252

Coronary interventions

A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold

Jamshidi P, Nyffenegger T, Sabti Z, Buset E, Toggweiler S, Kobza R, Cuculi F

April 20, 2016 | 10.4244/EIJV11I13A287

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Treatment of secondary mitral regurgitation in patients with heart failure

Marco Metra et al

This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....

Coronary flow capacity: where to next?

Nils P. Johnson

Joint EAPCI/ACVC expert consensus document on pVADs

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease